Conclusion: Greater attention to dialysis adequacy, hematocrit levels, nutrition assessment, weight monitoring, and diet therapy are recommended.
Safety monitoring included physical examination, vital sign assessment, weight, electrocardiogram, and adverse event recording.
On enrollment a detailed history was taken, physical examination and anthropometric assessment (weight, height) were carried out.
(E.G. BP, Cholesterol, CHD Risk assessment, Weight management, Physical activity advice) What do you think of these services?
All participants underwent physical examination including anthropometric assessment (weight, height, BMI, waist circumference) and had no medical or surgical history.
The pregnancy outcomes (determined by the neonatal assessment: weight, length and physical examination findings) were similar in both treatment groups.
At initial assessment, weight was 95.9 kg (above the 99.6th centile) with a height of 147 cm (between 10- 25th centile).
Clinical benefit was evaluated weekly, and was based on KS assessment, weight measurement, evaluation of pain intensity (using a visual analogue scale), and analgesic consumption.
The examination included anthropometric assessment (weight, height, waist, and hip circumference) and a questionnaire that included items on medical history and lifestyle variables (cigarette smoking, and physical activity).
The children were submitted to a nutritional assessment (weight and height) and their mothers answered a standardized pre-coded questionnaire including information on socioeconomic, demographic, reproductive, and health characteristics.
Both measures of weight perception (weight assessment and weight concern) were more favourable for liraglutide than glimepiride.
